COVID-19 en pacientes con Lupus Eritematoso Sistémico

Montiel, Dora; Figueredo, Hugo; Jarolin, Magali; Sánchez, Luis; Torres, Estela; Sobarzo, Patricia; Taboada, Patricia.
Rev. cient. cienc. salud ; 3(2): [46-53], 20211200.
Artículo en Español | BDNPAR | ID: biblio-1348976

Documentos relacionados

  1. The impact of the COVID-19 pandemic on SLE.
  2. [Pathogenesis of systemic lupus erythematosus (LES)].
  3. Rate of Recovery and Symptomatic Efficacy of a Polyherbal AYUSH Formulation in the Treatment of SARS-CoV-2 Disease: A Single-arm Trial.
  4. COVID-19 in patients with systemic lupus erythematosus: A systematic review.
  5. SARS-CoV­2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
  6. Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center.
  7. Efficacy and safety of hydroxychloroquine for treatment of mild SARS-CoV-2 infection and prevention of COVID-19 severity in pregnant and postpartum women: A randomized, double-blind, placebo-controlled trial.
  8. Pharmacokinetics under the COVID-19 storm.
  9. Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.
  10. Safety and efficacy of hydroxychloroquine for treatment of non-severe COVID-19 among adults in Uganda: a randomized open label phase II clinical trial.